Long-term survival and toxicity in small cell lung cancer. Southwest oncology group study

Keyphrases

• Long-term Survival 100%
• Small Cell Lung Cancer 100%
• Nitrosourea 100%
• Group Studies 100%
• Southwest Oncology Group 100%
• Long-term Toxicity 100%
• Liver 50%
• Treatment-related 50%
• Radiotherapy 50%
• Radiation Therapy 50%
• Diuretics 50%
• Central Nervous System 50%
• Disease-free Survival 50%
• Extensive-stage 50%
• Treatment Phase 50%
• Dementia 50%
• Long-term Survivors 50%
• Doxorubicin 50%
• Combination Chemotherapy 50%
• High Incidence 50%
• Neurologic Complications 50%
• Cerebrovascular Accident 50%
• Disability 50%
• Digitalis 50%
• Methotrexate 50%
• Congestive Cardiomyopathy 50%
• Hematological Abnormalities 50%
• Orthostatic Hypotension 50%
• Treatment Toxicity 50%
• Late Relapse 50%
• Pain Syndrome 50%
• Chronic Treatment 50%
• Incidence of Complication 50%
• Induction Period 50%
• Limited Disease 50%
• Postherpetic Pain 50%
• Organic Brain Syndrome 50%
• Second Primary Malignancy 50%
• Late Recurrence 50%
• Neurologic Problems 50%

Medicine and Dentistry

• Diseases 100%
• Oncology 100%
• Radiation Therapy 100%
• Long Term Survival 100%
• Nitrosourea 100%
• Small Cell Lung Cancer 100%
• Second Cancer 50%
• Recurrent Disease 50%
• Diuretics 50%
• Central Nervous System 50%
• Disease Free Survival 50%
• Apoplexy 50%
• Doxorubicin 50%
• Neurological Complication 50%
• Methotrexate 50%
• Dilated Cardiomyopathy 50%
• Orthostatic Hypotension 50%
• Postherpetic Neuralgia 50%
• Organic Brain Syndrome 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Nitrosourea 100%
• Long Term Survival 100%
• Small Cell Lung Cancer 100%
• Recurrent Disease 50%
• Chemotherapy 50%
• Cerebrovascular Accident 50%
• Doxorubicin 50%
• Diuretics 50%
• Methotrexate 50%
• Second Cancer 50%
• Congestive Cardiomyopathy 50%
• Orthostatic Hypotension 50%
• Disease Free Survival 50%
• Postherpetic Neuralgia 50%
• Neurological Complication 50%
• Organic Brain Syndrome 50%